Stent fabrication via tubular casting processes
Tubular casting processes, such as dip-coating, may be used to form substrates from polymeric solutions which may be used to fabricate implantable devices such as stents. The polymeric substrates may have multiple layers which retain the inherent properties of their starting materials and which are sufficiently ductile to prevent brittle fracture. Parameters such as the number of times the mandrel is immersed, the duration of time of each immersion within the solution, as well as the delay time between each immersion or the drying or curing time between dips and withdrawal rates of the mandrel from the solution may each be controlled to result in the desired mechanical characteristics. Additional post-processing may also be utilized to further increase strength of the substrate or to alter its shape.
1. A polymeric stent, comprising:
a stent scaffold formed from a polymeric substrate, wherein the polymeric substrate is formed from a polymeric solution having an inherent viscosity of about 4.3 dl/g to about 8.4 dl/g, wherein the scaffold has a delivery diameter when secured upon a catheter and an expanded diameter when deployed from the catheter, where the expanded diameter is larger than the delivery diameter,
wherein the stent scaffold is formed by multiple dip-coated layers of the polymeric substrate, wherein a degree of crystallinity of the multiple dip-coated layers is between about 20% and 46%,
at least one layer of barium sulfate incorporated into the polymeric substrate, and
wherein the scaffold is configured to self-expand by reverting over a predetermined period of time to its expanded diameter via a shape memory effect imparted to the scaffold when deployed after being reduced in diameter by up to 83%.
2. The stent of claim 1 wherein the expanded diameter of the scaffold is defined by a mandrel upon which the polymeric substrate is formed.
3. The stent of claim 1 wherein the polymeric substrate has a length of 1 to 40 cm.
4. The stent of claim 1 wherein the expanded diameter of the scaffold is between 3 to 9 mm.
5. The stent of claim 1 wherein the scaffold is adapted to curve up to 180° about a 1 cm curvature radius without fracture formation.
6. The stent of claim 1 wherein the stent is adapted to exhibit a percent reduction in axial length of between 10% to 30% without fracture formation when placed under an axial load.
7. The stent of claim 1 , wherein the scaffold is configured to self-expand at normal body temperatures by reverting over the predetermined period of time to its expanded diameter via a shape memory effect imparted to the scaffold when deployed.
8. The stent of claim 7 , wherein said normal body temperatures is between about 36° C. and 38° C.
9. A polymeric stent, comprising:
a stent scaffold formed from a polymeric substrate, wherein the polymeric substrate is formed from a polymeric solution having an inherent viscosity of about 4.3 dl/g to about 8.4 dl/g, wherein the scaffold has a delivery diameter when secured upon a catheter and an expanded diameter when deployed from the catheter, where the expanded diameter is larger than the delivery diameter,
wherein the stent scaffold is formed by multiple dip-coated layers of the polymeric substrate, wherein a degree of crystallinity of the multiple dip-coated layers is between about 20% and 46%,
at least one layer of barium sulfate incorporated into the polymeric substrate, and
wherein the scaffold is configured to self-expand by reverting over a predetermined period of time to its expanded diameter via a shape memory effect imparted to the scaffold when deployed after being reduced in diameter between 5% to 70%.
10. The stent of claim 9 wherein the expanded diameter of the scaffold is defined by a mandrel upon which the polymeric substrate is formed.
11. The stent of claim 9 wherein the polymeric substrate has a length of 1 to 40 cm.
12. The stent of claim 9 wherein the expanded diameter of the scaffold is between 3 to 9 mm.
13. The stent of claim 9 wherein the scaffold is adapted to curve up to 180° about a 1 cm curvature radius without fracture formation.
14. The stent of claim 9 wherein the stent is adapted to exhibit a percent reduction in axial length of between 10% to 30% without fracture formation when placed under an axial load.
15. The stent of claim 9 , wherein the scaffold is configured to self-expand at normal body temperatures by reverting over the predetermined period of time to its expanded diameter via a shape memory effect imparted to the scaffold when deployed.
16. The stent of claim 15 , wherein said normal body temperatures is between about 36° C. and 38° C.